Retinoic acid treatment of human neuroblastoma cells induces neurite outgrowth and reduces cell migration, effects that are enhanced by concurrent FOXP2 overexpression (Devanna et al, 2014), suggesting that the gene may modulate retinoic acid signaling in the developing brain. This evidence concerns the gene FOXP2 and neuroblastoma.